MRES OTC
Institute of Biomedical Research Corp.
1W: -20.4%
1M: -56.2%
3M: +86.2%
YTD: -37.5%
1Y: -71.8%
3Y: -93.1%
5Y: -89.5%
$0.00
-0.00 (-14.63%)
Weekly Expected Move ±26.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-50M
Net Income
-16411.7% YoY
$-0M
Free Cash Flow
+45.9% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE301783.0%
ROA-13804.0%
ROIC-6062.7%
Valuation
P/E-4.8
P/B-8.7
EV/EBITDA126.9
Leverage
Debt/Equity2.39
Current Ratio0.00
Interest Cov.-519.3x
Quality Scores
Piotroski F1/9
Altman Z-117.92
Beneish M0.00